KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sarepta Therapeutics (SRPT) Asset Utilization Ratio (2017 - 2025)

Sarepta Therapeutics (SRPT) has 13 years of Asset Utilization Ratio data on record, last reported at 0.09 in Q3 2025.

  • For Q3 2025, Asset Utilization Ratio fell 113.14% year-over-year to 0.09; the TTM value through Sep 2025 reached 0.09, down 113.14%, while the annual FY2024 figure was 0.03, 91.89% down from the prior year.
  • Asset Utilization Ratio reached 0.09 in Q3 2025 per SRPT's latest filing, down from 0.22 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.66 in Q3 2024 and bottomed at 0.09 in Q3 2025.
  • Average Asset Utilization Ratio over 5 years is 0.24, with a median of 0.22 recorded in 2025.
  • Peak YoY movement for Asset Utilization Ratio: skyrocketed 202.45% in 2024, then crashed 113.14% in 2025.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.22 in 2021, then fell by 10.59% to 0.2 in 2022, then skyrocketed by 57.19% to 0.31 in 2023, then dropped by 28.37% to 0.22 in 2024, then tumbled by 139.64% to 0.09 in 2025.
  • Per Business Quant database, its latest 3 readings for Asset Utilization Ratio were 0.09 in Q3 2025, 0.22 in Q2 2025, and 0.14 in Q1 2025.